vs
亚什兰（ASH）与Aveanna Healthcare Holdings, Inc.（AVAH）财务数据对比。点击上方公司名可切换其他公司
Aveanna Healthcare Holdings, Inc.的季度营收约是亚什兰的1.6倍（$621.9M vs $386.0M），Aveanna Healthcare Holdings, Inc.净利率更高（2.3% vs -3.1%，领先5.4%），Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs -4.7%），过去两年Aveanna Healthcare Holdings, Inc.的营收复合增速更高（14.0% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
ASH vs AVAH — 直观对比
营收规模更大
AVAH
是对方的1.6倍
$386.0M
营收增速更快
AVAH
高出26.9%
-4.7%
净利率更高
AVAH
高出5.4%
-3.1%
两年增速更快
AVAH
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $621.9M |
| 净利润 | $-12.0M | $14.1M |
| 毛利率 | 27.2% | 32.6% |
| 营业利润率 | -1.6% | 8.6% |
| 净利率 | -3.1% | 2.3% |
| 营收同比 | -4.7% | 22.2% |
| 净利润同比 | 92.7% | 132.8% |
| 每股收益（稀释后） | $-0.26 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHAVAH
| Q4 25 | $386.0M | — | ||
| Q3 25 | $477.0M | $621.9M | ||
| Q2 25 | $463.0M | $589.6M | ||
| Q1 25 | $479.0M | $559.2M | ||
| Q4 24 | $405.0M | $519.9M | ||
| Q3 24 | $521.0M | $509.0M | ||
| Q2 24 | $544.0M | $505.0M | ||
| Q1 24 | $575.0M | $490.7M |
净利润ASHAVAH
| Q4 25 | $-12.0M | — | ||
| Q3 25 | $31.0M | $14.1M | ||
| Q2 25 | $-742.0M | $27.0M | ||
| Q1 25 | $31.0M | $5.2M | ||
| Q4 24 | $-165.0M | $29.2M | ||
| Q3 24 | $17.0M | $-42.8M | ||
| Q2 24 | $6.0M | $13.9M | ||
| Q1 24 | $120.0M | $-11.2M |
毛利率ASHAVAH
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | 32.6% | ||
| Q2 25 | 28.5% | 35.8% | ||
| Q1 25 | 30.7% | 32.8% | ||
| Q4 24 | 27.4% | 33.0% | ||
| Q3 24 | 33.2% | 31.4% | ||
| Q2 24 | 34.2% | 31.3% | ||
| Q1 24 | 28.0% | 29.7% |
营业利润率ASHAVAH
| Q4 25 | -1.6% | — | ||
| Q3 25 | 12.8% | 8.6% | ||
| Q2 25 | -152.9% | 13.6% | ||
| Q1 25 | 10.6% | 9.3% | ||
| Q4 24 | -44.2% | 8.8% | ||
| Q3 24 | 6.1% | 6.7% | ||
| Q2 24 | -11.2% | 7.4% | ||
| Q1 24 | 3.7% | 4.7% |
净利率ASHAVAH
| Q4 25 | -3.1% | — | ||
| Q3 25 | 6.5% | 2.3% | ||
| Q2 25 | -160.3% | 4.6% | ||
| Q1 25 | 6.5% | 0.9% | ||
| Q4 24 | -40.7% | 5.6% | ||
| Q3 24 | 3.3% | -8.4% | ||
| Q2 24 | 1.1% | 2.8% | ||
| Q1 24 | 20.9% | -2.3% |
每股收益（稀释后）ASHAVAH
| Q4 25 | $-0.26 | — | ||
| Q3 25 | $0.83 | $0.06 | ||
| Q2 25 | $-16.21 | $0.13 | ||
| Q1 25 | $0.65 | $0.03 | ||
| Q4 24 | $-3.50 | $0.15 | ||
| Q3 24 | $0.34 | $-0.22 | ||
| Q2 24 | $0.12 | $0.07 | ||
| Q1 24 | $2.39 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $145.9M |
| 总债务越低越好 | $1.4B | $1.3B |
| 股东权益账面价值 | $1.9B | $9.2M |
| 总资产 | $4.5B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.74× | 141.83× |
8季度趋势，按日历期对齐
现金及短期投资ASHAVAH
| Q4 25 | $304.0M | — | ||
| Q3 25 | $215.0M | $145.9M | ||
| Q2 25 | $207.0M | $100.7M | ||
| Q1 25 | $168.0M | $71.5M | ||
| Q4 24 | $219.0M | $84.3M | ||
| Q3 24 | $300.0M | $78.5M | ||
| Q2 24 | $399.0M | $47.7M | ||
| Q1 24 | $439.0M | $42.6M |
总债务ASHAVAH
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.3B |
股东权益ASHAVAH
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | $9.2M | ||
| Q2 25 | $1.9B | $-12.0M | ||
| Q1 25 | $2.6B | $-100.1M | ||
| Q4 24 | $2.6B | $-123.6M | ||
| Q3 24 | $2.9B | $-156.4M | ||
| Q2 24 | $3.0B | $-119.0M | ||
| Q1 24 | $3.1B | $-136.3M |
总资产ASHAVAH
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.6B | $1.8B | ||
| Q2 25 | $4.6B | $1.8B | ||
| Q1 25 | $5.2B | $1.7B | ||
| Q4 24 | $5.2B | $1.7B | ||
| Q3 24 | $5.6B | $1.6B | ||
| Q2 24 | $5.7B | $1.7B | ||
| Q1 24 | $5.9B | $1.6B |
负债/权益比ASHAVAH
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | 141.83× | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $33.2M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | 2.36× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHAVAH
| Q4 25 | $125.0M | — | ||
| Q3 25 | $40.0M | $33.2M | ||
| Q2 25 | $115.0M | $51.6M | ||
| Q1 25 | $9.0M | $-8.6M | ||
| Q4 24 | $-30.0M | $13.4M | ||
| Q3 24 | $80.0M | $29.4M | ||
| Q2 24 | $127.0M | $1.8M | ||
| Q1 24 | $54.0M | $-12.0M |
自由现金流ASHAVAH
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $98.0M | — | ||
| Q1 24 | $20.0M | — |
自由现金流率ASHAVAH
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 3.5% | — |
资本支出强度ASHAVAH
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 5.9% | — |
现金转化率ASHAVAH
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | 2.36× | ||
| Q2 25 | — | 1.91× | ||
| Q1 25 | 0.29× | -1.66× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | 0.13× | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
